2026-04-13 13:16 |
[DZNE-2026-00391]
Journal Article
Brem, A.-K. ; Khan, Z. ; Radermacher, J. ; et al
Screening for Alzheimer’s disease in the community using an AI-driven screening platform: design of the PREDICTOM study
Recent developments in physiological, imaging and digital biomarkers combined with the approval of new disease-modifying drugs against Alzheimer's disease (AD) and diagnostic blood tests provide an opportunity to shift the first diagnostic steps to the home-setting. While these novel biomarkers enable scalable screening and earlier detection and treatment of AD, they require an evaluation of their accuracy, feasibility, and safety in primary care and the community setting.The aim of PREDICTOM is to develop and test the accuracy of an artificial intelligence (AI) driven screening platform for the risk assessment and early detection of AD to extend the clinical pathway to home-based screening using established and novel biomarkers.PREDICTOM is a European (Norway, UK, Belgium, France, Switzerland, Germany, Spain) observational, prospective cohort study using a cloud-based platform that stores a digitalised journey for each participant and provides a collection of artificial-intelligence (AI) algorithms and tools for risk assessment and early diagnosis and prognosis.Cohort 1 consists of 4000 adults aged 50 years or older at risk of developing AD. [...]
Restricted: PDF PDF (PDFA);
Detailed record - Similar records
|
2026-04-13 13:14 |
Detailed record - Similar records
|
2026-04-13 13:07 |
Detailed record - Similar records
|
2026-04-13 13:05 |
Detailed record - Similar records
|
2026-04-13 13:03 |
Detailed record - Similar records
|
2026-04-13 12:57 |
Detailed record - Similar records
|
2026-04-13 12:55 |
[DZNE-2026-00385]
Journal Article
Pradhan, R. ; Sakib, M. S. ; Kaurani, L. ; et al
lncRNA Glelr modulates microglia inflammatory programs in association with PU.1.
Long non-coding RNAs (lncRNAs) are emerging as key regulators of brain function, but their contribution to microglial aging and neurodegenerative disease remains largely unknown. Because only 1.5% of the human genome encodes proteins, whereas the vast majority of transcripts belong to the largely unexplored non-coding RNAome, elucidating the functions of non-coding RNAs provides an unprecedented opportunity to expand the space for therapeutic discovery. [...]
Restricted: PDF PDF (PDFA);
Detailed record - Similar records
|
2026-04-13 11:39 |
Detailed record - Similar records
|
2026-04-13 11:38 |
Detailed record - Similar records
|
2026-04-13 11:37 |
Detailed record - Similar records
|
|
|